| P2093 | author name string | A Cerami | |
| | H Vlassara | |
| | R Bucala | |
| | T Koschinsky | |
| | Z Makita | |
| | S Grundy | |
| | G Vega | |
| P2860 | cites work | Accelerated age-related browning of human collagen in diabetes mellitus | Q24597835 |
| | THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM | Q29391553 |
| | Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity | Q29617216 |
| | Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications | Q34049428 |
| | Overexpression of low density lipoprotein (LDL) receptor eliminates LDL from plasma in transgenic mice | Q34175241 |
| | Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes | Q34180296 |
| | Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking | Q34180583 |
| | Advanced glycosylation: chemistry, biology, and implications for diabetes and aging | Q34351918 |
| | Receptor-mediated catabolism of low density lipoprotein in man. Quantitation using glucosylated low density lipoprotein | Q35205750 |
| | Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitus | Q35822678 |
| | Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties | Q36356851 |
| | Lipid advanced glycosylation: pathway for lipid oxidation in vivo | Q36412583 |
| | Effects of age and diabetes mellitus on the solubility and nonenzymatic glucosylation of human skin collagen | Q36999791 |
| | Altered Metabolism (In Vivo and In Vitro) of Plasma Lipoproteins after Selective Chemical Modification of Lysine Residues of the Apoproteins | Q37041323 |
| | Glycosylated haemoglobin: measurement and clinical use. | Q37184010 |
| | High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules | Q37529086 |
| | The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis | Q37605132 |
| | The chemistry of the Maillard reaction under physiological conditions: a review | Q38691799 |
| | The pathogenesis of atherosclerosis--an update | Q39726917 |
| | Inhibition of lipoprotein binding to cell surface receptors of fibroblasts following selective modification of arginyl residues in arginine-rich and B apoproteins | Q40099596 |
| | Diabetes as an atherogenic factor. | Q40176087 |
| | Lipoprotein disorders in diabetes mellitus | Q40802337 |
| | Diabetes and cardiovascular disease. The Framingham study | Q41509493 |
| | Lipoprotein-receptor interactions | Q43868984 |
| | Advanced glycosylation end products in patients with diabetic nephropathy | Q44031994 |
| | Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity | Q46871536 |
| | Interpretation of the thiobarbituric acid reactivity of rat liver and brain homogenates in the presence of ferric ion and ethylenediaminetetraacetic acid | Q48487261 |
| | Metabolism of low-density lipoprotein from patients with diabetic hypertriglyceridemia by cultured human skin fibroblasts. | Q51639825 |
| | Hemoglobin-AGE: a circulating marker of advanced glycosylation | Q67563382 |
| | Immunochemical detection of advanced glycosylation end products in vivo | Q67895447 |
| | Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling | Q68094187 |
| | Abnormalities in plasmas concentrations of lipoproteins and fibrinogen in Type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion | Q68365130 |
| | Surface binding, internalization and degradation by cultured human fibroblasts of low density lipoproteins isolated from type 1 (insulin-dependent) diabetic patients: changes with metabolic control | Q70253629 |
| | Collagen aging in vitro by nonenzymatic glycosylation and browning | Q70458958 |
| | Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure | Q72681292 |
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dyslipidemia | Q66291209 |
| P1104 | number of pages | 5 | |
| P304 | page(s) | 9441-9445 | |
| P577 | publication date | 1994-09-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency | |
| P478 | volume | 91 | |